Astrana Health (ASTH) Invested Capital (2011 - 2026)

Astrana Health has disclosed Invested Capital across 16 years of filings, most recently posting $863.1 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $863.1 million, up 13.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $863.1 million (up 13.12% YoY), and the FY2025 annual result was $827.2 million, up 13.92% from the prior year.
• Invested Capital came in at $863.1 million for Q1 2026 at Astrana Health, up from $827.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $863.1 million in Q1 2026 to a low of $474.4 million in Q1 2022.
• The 5-year median for Invested Capital is $659.6 million (2024), against an average of $660.3 million.
• Across the five-year window, Invested Capital surged 36.53% in 2022 and rose 12.0% in 2025, its largest moves.
• Astrana Health's Invested Capital stood at $550.2 million in 2022, then grew by 12.38% to $618.3 million in 2023, then gained by 17.43% to $726.1 million in 2024, then gained by 13.92% to $827.2 million in 2025, then rose by 4.34% to $863.1 million in 2026.
• The last three Invested Capital figures came in at $863.1 million (Q1 2026), $827.2 million (Q4 2025), and $823.4 million (Q3 2025), per Business Quant data.